Zhang Q, Chen B, Liu G. Artificial intelligence can dynamically adjust strategies for auxiliary diagnosing respiratory diseases and analyzing potential pathological relationships.
J Breath Res 2023;
17:046007. [PMID:
37582347 DOI:
10.1088/1752-7163/acf065]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Accepted: 08/15/2023] [Indexed: 08/17/2023]
Abstract
Respiratory diseases are one of the leading causes of human death and exacerbate the global burden of non-communicable diseases. Finding a method to assist clinicians pre-diagnose these diseases is an urgent task. Existing artificial intelligence-based methods can improve the clinical diagnosis efficiency, but still face challenges. For example, the lack of interpretability, the problem of information redundancy or missing caused by only using static data, the difficulty of model to learn the interdependence between features, and the performance of model is limited by sparse datasets, etc. To alleviate these problems, we propose a novel RQPA-Net. It consists of Q&A diagnosis module (QAD) and pathological inference module (PI). The QAD is responsible for interacting with patients, adjusting inquiry strategies dynamically and collecting effective information for disease diagnosis. The designed multi-subspace network can alleviate the problem that classical method is difficult to understand the interdependence between features. The deep reinforcement learning designed also can alleviate the problem of classical methods lack of interpretability. The PI is responsible for reasoning potential pathological relationships between diseases or symptoms based on existing knowledge. Through integrating the advantages of deep learning and reinforcement learning techniques, PI can handle sparse datasets. Finally, for auxiliary diagnosis, the model achieves 0.9780 ± 0.0002 Recall, 0.9778 ± 0.0003 Acc, 0.9779 ± 0.0003 Precision and 0.9780 ± 0.0003 F1-score on the test set. In terms of assisting pathological analysis, compared with the end-to-end model, our model achieves higher comprehensive performance on different tasks and datasets with different degrees of sparsity. Even in sparse datasets, it can effectively infer potential associations between diseases or symptoms, and has higher potential clinical application. In this paper, we propose a novel network structure, which can not only assist doctors in diagnosing diseases, but also contribute to explore the potential disease mechanisms. It provides a new perspective for integrating AI technology and clinical practice.
Collapse